546
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Preoperative NT-proBNP independently predicts outcome in patients with acute coronary syndrome undergoing CABG*

, , , , &
Pages 28-35 | Received 14 Jun 2012, Accepted 12 Sep 2012, Published online: 10 Oct 2012

References

  • St Andre AC, DelRossi A. Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med. 2005;33:2082–93.
  • Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.
  • Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA. 1992;267:2344–8.
  • Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321–8.
  • de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:316–22.
  • Broch K, Eek C, Wergeland R, Ueland T, Skardal R, Aukrust P, . NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome. Scand Cardiovasc J. 2012;46:65–71.
  • Cuthbertson BH, Croal BL, Rae D, Gibson PH, McNeilly JD, Jeffrey RR, . N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. Br J Anaesth. 2009;103:647–53. Epub 2009 Aug 27.
  • Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, . Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004;43:1873–9.
  • Fox AA, Muehlschlegel JD, Body SC, Shernan SK, Liu KY, Perry TE, . Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology. 2010;112:842–51.
  • Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, . A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg. 2004;98:11–9, table of contents.
  • Litton E, Ho KM. The use of pre-operative brain natriuretic peptides as a predictor of adverse outcomes after cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2012;41:525–34.
  • Fellahi JL, Daccache G, Makroum Y, Massetti M, Gerard JL, Hanouz JL. The prognostic value of B-type natriuretic peptide after cardiac surgery: a comparative study between coronary artery bypass graft surgery and aortic valve replacement. J Cardiothorac Vasc Anesth. 2012;26:624–30.
  • Vidlund M, Håkanson E, Friberg Ö, Juhl-Andersen S, Holm J, Vanky F, . GLUTAMICS – a randomized clinical trial on glutamate infusion in patients operated for acute coronary syndrome. J Thorac Cardiovasc Surg. 2012;144:922–30.
  • Svedjeholm R, Hakanson E, Szabo Z. Routine SvO2 measurement after CABG surgery with a surgically introduced pulmonary artery catheter. Eur J Cardiothorac Surg. 1999; 16:450–7.
  • Holm J, Hakanson E, Vanky F, Svedjeholm R. Mixed venous oxygen saturation predicts short- and long-term outcome after coronary artery bypass grafting surgery: a retrospective cohort analysis. Br J Anaesth. 2011;107:344–50.
  • Fox AA, Shernan SK, Collard CD, Liu KY, Aranki SF, DeSantis SM, . Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008;136:452–61.
  • Pedrazzini GB, Masson S, Latini R, Klersy C, Rossi MG, Pasotti E, . Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol. 2008;102:749–54.
  • Fellahi JL, Daccache G, Rubes D, Massetti M, Gerard JL, Hanouz JL. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery? J Cardiothorac Vasc Anesth. 2010;2010:29.
  • Sykes E, Karcher RE, Eisenstadt J, Tushman DA, Balasubramaniam M, Gusway J, Perason VJ. Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol. 2005;123:584–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.